Publication | Open Access
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study
40
Citations
26
References
2022
Year
In this large cohort, we confirm previous data about cladribine effectiveness on disease activity and disability worsening and provide information on response predictors that might inform therapeutic choices.
| Year | Citations | |
|---|---|---|
Page 1
Page 1